Development and psychometric evaluation of the Basic Documentation for Psycho-Oncology, a tool for standardized assessment of cancer patients

被引:35
作者
Knight, Lucie [1 ]
Mussell, Monika [1 ]
Brandl, Tobias [2 ,3 ]
Herschbach, Peter [2 ,3 ]
Marten-Mittag, Birgitt [2 ,3 ]
Treiber, Martina [4 ]
Keller, Monika [1 ]
机构
[1] Heidelberg Univ, Med Ctr, Dept Psychosomat & Gen Internal Med, Div Psychooncol, D-69120 Heidelberg, Germany
[2] Tech Univ Munich, Inst Psychosomat Med Psychotherapy & Med Psychol, D-8000 Munich, Germany
[3] Tech Univ Munich, Outpatient Clin Psychosomat Med Psychotherapy & M, D-8000 Munich, Germany
[4] Heidelberg Univ, Med Ctr, Dept Radiat Oncol, D-69120 Heidelberg, Germany
关键词
psychosocial distress; structured assessment; expert rating scale; psycho-oncology; cancer patients; audit;
D O I
10.1016/j.jpsychores.2008.01.003
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: This study describes the development and psychometric evaluation of the Basic Documentation for Psycho-Oncology (PO-Bado), an expert rating scale designed for the comprehensive assessment of psychosocial and physical distress in cancer patients. While there are many self-report measures (usually used for screening purposes), the PO-Bado is the first standardized clinician-administered instrument to guide professionals in a focused and structured psycho-oncological assessment. Methods: The validation procedure was performed in 596 patients from different settings of cancer care, including all cancer sites and stages of the disease. The psychometric evaluation included (a) determination of the factorial structure, (b) homogeneity of scales and interrater reliability, (c) convergent and discriminant validities, and (d) examination of sensitivity to change. Results: The final version of the PO-Bado includes two scales: the physical distress scale (four items) and the psychological distress scale (eight items). A manual and an interview guideline were developed alongside. The psychometric properties suggest that the PO-Bado is a reliable and valid tool used to assess and to differentiate the distress of patients with cancer, as well as treatment-related changes in distress. Conclusion: We suggest that the PO-Bado is a useful tool that is applicable in different oncology settings. It complements self-report measures and provides a structured format for focused psycho-oncological assessment and intervention. The two-dimensional structure allows differentiation between physical and psychological problems, assisting professionals in their diagnostic efforts and in providing appropriate support or treatment. When used consistently across professions and settings, the PO-Bado can form the basis for audit and interdisciplinary communication. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:373 / 381
页数:9
相关论文
共 40 条
  • [1] [Anonymous], 2003, J Natl Comp Canc Netw, V1, P344, DOI DOI 10.6004/JNCCN.2003.0031
  • [2] [Anonymous], 2001, International Journal of Methods in Psychiatric Research, DOI [DOI 10.1002/MPR.103, 10.1002/mpr.103]
  • [3] PSYCHOLOGICAL REACTIONS IN PATIENTS WITH MALIGNANT-MELANOMA
    BRANDBERG, Y
    MANSSONBRAHME, E
    RINGBORG, U
    SJODEN, PO
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (02) : 157 - 162
  • [4] Cancer distress screening - Needs, models, and methods
    Carlson, LE
    Bultz, BD
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 2003, 55 (05) : 403 - 409
  • [5] Cohen J., 1988, POWERSTATISTICALSCIE, DOI 10.4324/9780203771587
  • [6] Derogatis L.R., 1993, The Brief Symptom Inventory (BSI) administration, scoring, and procedures manual, V4th
  • [7] Psychiatric morbidity and its recognition by doctors in patients with cancer
    Fallowfield, L
    Ratcliffe, D
    Jenkins, V
    Saul, J
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (08) : 1011 - 1015
  • [8] Fletcher Astrid, 1992, British Medical Journal, V305, P1145
  • [9] PSYCHOLOGICAL MORBIDITY IN NEWLY REFERRED PATIENTS WITH CANCER
    FORD, S
    LEWIS, S
    FALLOWFIELD, L
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 1995, 39 (02) : 193 - 202
  • [10] Fransson P, 2001, SUPPORT CARE CANCER, V9, P187